AbstractAggregation is mediated by local unfolding to allow aggregation “hot spot(s)” to become solvent exposed and available to associate with a hot spot on another partially unfolded protein. Historically, the unfolding of either the crystallizable fragment (Fc) or the antigen binding fragment (Fab) regions of a given monoclonal antibody (MAb) has been implicated in aggregation, with differing results across different proteins. The present work focuses on separately quantifying the aggregation kinetics of isolated Fc, isolated Fab, and intact MAb as a function of pH under accelerated (high temperature) conditions. The results show that both Fab and Fc are aggregation prone and compete within the same MAb
The term protein aggregation is used in pharmaceutical biotechnology literature to describe a collec...
AbstractProtein A chromatography is a near-ubiquitous method of mAb capture in bioprocesses. The use...
Aggregation is a critical issue that hampers the development of monoclonal antibody therapeutics (Ma...
AbstractAggregation is mediated by local unfolding to allow aggregation “hot spot(s)” to become solv...
Purpose: To identify the aggregation mechanism and the stability characteristics of three different ...
Protein aggregation remains a major area of focus in the production of monoclonal antibodies. Improv...
ABSTRACT: Purpose: To study the effect of several operative parameters, particularly pH and salt con...
The spontaneous formation of aggregates presents an obstacle in the developability, manufacturabilit...
The Stability of Monoclonal Antibodies Monoclonal antibodies (mAbs) are antibodies which are homogen...
Roberts, Christopher J.Monoclonal antibodies (mAbs) are one of the leading protein-based drug candid...
Aggregation has been identified as one of the major degradation pathways that affect the quality and...
AbstractFinding excipients which mitigate protein self-association and aggregation is an important t...
Computationally-guided semi-rational design has significant potential for improving the aggregation ...
The development of therapeutic monoclonal antibodies (mAbs) can be hindered by their tendency to agg...
Protein aggregation is the underlying cause of many diseases, and also limits the usefulness of many...
The term protein aggregation is used in pharmaceutical biotechnology literature to describe a collec...
AbstractProtein A chromatography is a near-ubiquitous method of mAb capture in bioprocesses. The use...
Aggregation is a critical issue that hampers the development of monoclonal antibody therapeutics (Ma...
AbstractAggregation is mediated by local unfolding to allow aggregation “hot spot(s)” to become solv...
Purpose: To identify the aggregation mechanism and the stability characteristics of three different ...
Protein aggregation remains a major area of focus in the production of monoclonal antibodies. Improv...
ABSTRACT: Purpose: To study the effect of several operative parameters, particularly pH and salt con...
The spontaneous formation of aggregates presents an obstacle in the developability, manufacturabilit...
The Stability of Monoclonal Antibodies Monoclonal antibodies (mAbs) are antibodies which are homogen...
Roberts, Christopher J.Monoclonal antibodies (mAbs) are one of the leading protein-based drug candid...
Aggregation has been identified as one of the major degradation pathways that affect the quality and...
AbstractFinding excipients which mitigate protein self-association and aggregation is an important t...
Computationally-guided semi-rational design has significant potential for improving the aggregation ...
The development of therapeutic monoclonal antibodies (mAbs) can be hindered by their tendency to agg...
Protein aggregation is the underlying cause of many diseases, and also limits the usefulness of many...
The term protein aggregation is used in pharmaceutical biotechnology literature to describe a collec...
AbstractProtein A chromatography is a near-ubiquitous method of mAb capture in bioprocesses. The use...
Aggregation is a critical issue that hampers the development of monoclonal antibody therapeutics (Ma...